Identifying inhibitors of Trypanosoma cruzi nucleoside diphosphate kinase 1 as potential repurposed drugs for Chagas’ disease

This publication has 66 references indexed in Scilit:

• SWEETLEAD: an In Silico Database of Approved Drugs, Regulated Chemicals, and Herbal Isolates for Computer-Aided Drug Discovery
  PLOS ONE, 2013
• Mycobacterium tuberculosis Nucleoside Diphosphate Kinase Inactivates Small GTPases Leading to Evasion of Innate Immunity
  PLOS Pathogens, 2013
• Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign
  PLOS Neglected Tropical Diseases, 2012
• Chagas disease
  The Lancet, 2010
• Fpocket: An open source platform for ligand pocket detection
  BMC Bioinformatics, 2009
• NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1
  Molecular Cancer Therapeutics, 2009
• YNK1, the yeast homolog of human metastasis suppressor NM23, is required for repair of UV radiation- and etoposide-induced DNA damage
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
• Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages
  Molecular and Biochemical Parasitology, 2008
• Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase
  British Journal of Cancer, 2007
• Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
  Journal of Theoretical Biology, 1976